Navyaa Sinha
Elk Grove,California
Summary
Medical student at CNU College of Medicine with strong clinical assessment skills, leadership experience in student governance, and a commitment to culturally sensitive, patient-centered care. Proven ability to lead initiatives, collaborate across teams, and contribute to clinical research and data analysis in diverse healthcare environments.
Overview
6
6
years of professional experience
1
1
Certification
Work History
Student Body Government
CNU College of Medicine
01.2024 - 02.2025
- Oversaw and supported over 100 student interest groups, ensuring compliance with institutional policies and alignment with our program's objectives.
- Reviewed, approved, and launched new student interest groups, including evaluation, and leadership onboarding.
- Supervised and collaborated with organization presidents and vice presidents, providing guidance on events and sustainability.
- Partnered in the planning and execution of school-wide events, including academic, wellness, and community initiatives.
- Served as a liaison between students, faculty, and administration to enhance the student experience.
Community Service Volunteer
Clinica Tepati
09.2023 - 02.2025
- Part of student run free clinic.
- Help provide healthcare to the underserved Latino community.
- Run rounds, take history and perform physical exams on patients.
- Order appropriate labs with guidance of preceptor.
Community Service Volunteer
SEVA Clinic
09.2023 - 02.2025
- Provided free health screenings and vaccinations for the underserved Indian community.
- Counseled patients on hypertension, diabetes risk, lifestyle modification, and follow-up care.
- Identified abnormal screening results and guided patients on appropriate next steps.
- Collaborated with a student-run interdisciplinary team to deliver culturally sensitive care.
ACEing Autism Leader
CNU College of Medicine
10.2023 - 01.2025
- Help run weekly tennis camps for children with autism spectrum disorder, ages 4–18.
- Designed and facilitated adaptive tennis drills and games to accommodate a wide range of skill levels.
- Used sport-based activities to support the development of hand-eye coordination, motor skills, and confidence.
- Fostered social engagement, independence, and participation in structured group activities.
Research Assistant
UCSD Moores Cancer Center
09.2018 - 05.2023
- Principal Investigators: Dr. Thomas Kipps, MD, PhD & Dr. Charles Prussak, PharmD, PhD. Research immuno-oncology of CAR T-cells as a treatment for chronic lymphocytic leukemia (CLL) and solid tumors by determining therapeutic targets, engineering more effective CAR T-cells, and confirming efficacy and safety to develop best-in-class clinical treatments.
- Conducted translational immuno-oncology research on CAR T-cell therapies for chronic lymphocytic leukemia (CLL) and solid tumors, focusing on therapeutic target identification, CAR design, and preclinical safety and efficacy.
- Performed advanced wet-lab techniques such as flow cytometry, molecular cloning, mammalian cell culture, bacterial culture, viral vector production, and molecular assays.
- Isolated and genetically modified patient-derived T cells, including PBMCs, and CD3, CD4, and CD8 subsets.
- Executed immunologic functional assays, including ELISA, ELISPOT, cytokine profiling, and cytotoxic assays, to evaluate CAR T-cell activity.
- Contributed to data analysis, figure preparation, and manuscript development.
Education
Medical Student (MD) - Third Year
California Northstate University College of Medicine
05-2027
Bachelor of Science - Human Biology
University of California San Diego
Skills
- Patient assessment
- Clinical research
- Healthcare outreach
- Community engagement
- Data analysis
- Event planning
- Team collaboration
- Communication skills
Certification
BLS Certified
Abstracts and Presentations
- Emole A, Sinha N, Aboukhalil D, Eyvazzadeh A. First case report of late-onset ovarian hyperstimulation syndrome with right-sided pleural effusions following a spontaneous pregnancy during a luteal phase ovarian stimulation cycle. North American Proceedings in Gynecology and Obstetrics. Supplement; 2025.
- Maheta BJ, Bali M, Sinha N, Karashchuk I, Whang P, Bowman J, Puglisi J, Frezza EE. Improving trauma resource management: an analysis of U.S. public mass shooting data from 2014–2023. Poster presented at: American College of Surgeons Clinical Congress; October 2024; San Francisco, CA.
- Sinha N, Aboukhalil D, Razick DI, Monroe R, Sario EM, Khatri V. Does the chief executive officer’s educational background have an impact on academic hospital Leapfrog safety grades? Presented at: California Northstate University Research Day; 2024.
- Jamieson C, Murtadha J, Oh CS, Muldong M, Koutouan E, Kim J, Sinha N, et al. Pre-clinical studies to advance zilovertamab-based anti-ROR1 dual-specificity CAR T-cell therapy for metastatic prostate cancer. Journal of Urology. 2023;209(Suppl 4):e146.
- Oh CS, Sinha N, Choo HS, Muldong M, Murtadha J, Kim JW, Douglass-Lafer J, Clifton M, Xie B, Tran J, Chen S, So H, Vélez Luján J, Fernandez J, Shin C, Pham J, Shi H, Kaufmann GF, Widhopf GF II, Cohen EEW, Jamieson CAM, Kipps TJ, Prussak CE. Dual-targeting anti-ROR2 and anti-ROR1 chimeric antigen receptor T-cell immunotherapy against heterogeneous human liquid and solid tumors. Poster presented at: Moores Cancer Center Delivering Discoveries Scientific Retreat; October 11, 2022. Award of Excellence for Best Poster.
- Avsharian LC, Oh CS, Vora AA, Fernandez J, Shin C, Sinha N, Prussak CE, Crews L. Detection and CAR T-cell–directed targeting of inflammation-responsive Wnt pathway receptors on multiple myeloma cancer stem-like cells. Presented at: American Association for Cancer Research Annual Meeting; April 8–13, 2022; New Orleans, LA.
- Prussak CE, Oh C, Velez Lujan J, Lam S, Zhang J, Fernandez J, Sinha N, Pham J, Shi H, Shin C, Kaufmann GF, Widhopf GF II, Cohen EEW, Kipps TJ. Preclinical evaluation of anti-ROR1 CAR T cells employing a ROR1-binding single-chain variable fragment derived from the clinical-stage monoclonal antibody cirmtuzumab. Journal of Clinical Oncology. 2020;38(Suppl 5):41.
- Oh C, Velez Lujan J, Lam S, Zhang J, Fernandez J, Sinha N, Pham J, Shi H, Shin C, Tong N, Kaube L, Wang Z, Kaufmann GF, Widhopf GF II, Cohen EEW, Kipps TJ, Prussak CE. Cirmtuzumab (UC-961)–based anti-ROR1 CAR T-cell immunotherapy for treating human malignancies. Poster presented at: STEMCELL Technologies Southern California Immunology Virtual Poster Session; August 14, 2020.
- Oh C, Sinha N, Velez Lujan J, Muldong M, Fernandez J, Pham J, Shi H, Shin C, Tong N, Kaube L, Wang Z, Lam S, Zhang J, Gray C, Kaufmann GF, Widhopf GF II, Cohen EEW, Jamieson CAM, Kipps TJ, Prussak CE. Anti-ROR chimeric antigen receptor T-cell immunotherapy for human liquid and solid tumor cancers. Presented at: Moores Cancer Center Research Retreat; October 29, 2020.
- Oh C, Muldong M, Velez Lujan J, Kaube L, Sinha N, Fernandez J, Shin C, Pham J, Shi H, Tong N, Wang Z, Wu C, Lee S, Kulidjian A, Kaufmann GF, Kipps TJ, Jamieson CAM, Prussak CE. Cirmtuzumab-based anti-ROR1 CAR T-cell immunotherapy for treatment of lethal castration-resistant ROR1-positive prostate cancers. Poster presented at: STEMCELL Technologies Southern California Immunology Virtual Poster Session; November 12, 2020.
- Muldong M, Oh C, Velez Lujan J, Wu C, Lee S, Murtadha J, Sinha N, Fernandez J, Shi H, Pham J, Shin C, Kaube L, Tong N, Wang Z, Kulidjian A, Kaufmann GF, Kipps TJ, Prussak CE, Jamieson CAM. Advancing anti-ROR1 CAR-T cells: employing a cirmtuzumab-based CAR T-cell to eradicate lethal castration-resistant ROR1-positive prostate cancer. Poster presented at: Society for Basic Urologic Research Annual Meeting; November 11, 2020.
Languages
- English
- Hindi
Patents
- Sinha N. Sport training equipment. U.S. Patent US 9,724,561 B2. Issued August 8, 2017.
Manuscript Under Revision
- Emole A, Sinha N, Aboukhalil D, Gupta S, Eyvazzadeh A. Ovarian hyperstimulation syndrome with pleural effusion after unassisted pregnancy during a luteal-phase stimulation cycle. Fertility and Sterility. Case report. Manuscript under revision.
Publications
- Xian J, Sinha N, Girgis C, Oh CS, Cring MR, Widhopf GF II, Kipps TJ. Variant transcript of ROR1 ENST00000545203 does not encode ROR1 protein. Biomedicines. 2024;12(7):1573.
- Razick DI, Monroe R, Sario EM, Aboukhalil D, Sinha N, Khatri V. Does the chief executive officer’s educational background have an impact on academic hospital Leapfrog safety grades? Cureus. 2024;16(7):e64033.
Timeline
Student Body Government
CNU College of Medicine
01.2024 - 02.2025
ACEing Autism Leader
CNU College of Medicine
10.2023 - 01.2025
Community Service Volunteer
Clinica Tepati
09.2023 - 02.2025
Community Service Volunteer
SEVA Clinic
09.2023 - 02.2025
Research Assistant
UCSD Moores Cancer Center
09.2018 - 05.2023
Medical Student (MD) - Third Year
California Northstate University College of Medicine
Bachelor of Science - Human Biology
University of California San Diego